Literature DB >> 32807983

Rare genetic causes of complex kidney and urological diseases.

Emily E Groopman1, Gundula Povysil2, David B Goldstein2, Ali G Gharavi3,4,5.   

Abstract

Although often considered a single-entity, chronic kidney disease (CKD) comprises many pathophysiologically distinct disorders that result in persistently abnormal kidney structure and/or function, and encompass both monogenic and polygenic aetiologies. Rare inherited forms of CKD frequently span diverse phenotypes, reflecting genetic phenomena including pleiotropy, incomplete penetrance and variable expressivity. Use of chromosomal microarray and massively parallel sequencing technologies has revealed that genomic disorders and monogenic aetiologies contribute meaningfully to seemingly complex forms of CKD across different clinically defined subgroups and are characterized by high genetic and phenotypic heterogeneity. Investigations of prevalent genomic disorders in CKD have integrated genetic, bioinformatic and functional studies to pinpoint the genetic drivers underlying their renal and extra-renal manifestations, revealing both monogenic and polygenic mechanisms. Similarly, massively parallel sequencing-based analyses have identified gene- and allele-level variation that contribute to the clinically diverse phenotypes observed for many monogenic forms of nephropathy. Genome-wide sequencing studies suggest that dual genetic diagnoses are found in at least 5% of patients in whom a genetic cause of disease is identified, highlighting the fact that complex phenotypes can also arise from multilocus variation. A multifaceted approach that incorporates genetic and phenotypic data from large, diverse cohorts will help to elucidate the complex relationships between genotype and phenotype for different forms of CKD, supporting personalized medicine for individuals with kidney disease.

Entities:  

Mesh:

Year:  2020        PMID: 32807983      PMCID: PMC7772719          DOI: 10.1038/s41581-020-0325-2

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  211 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

Authors:  Abigail Liebow; Xingsheng Li; Timothy Racie; Julia Hettinger; Brian R Bettencourt; Nader Najafian; Patrick Haslett; Kevin Fitzgerald; Ross P Holmes; David Erbe; William Querbes; John Knight
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

Review 3.  Developing Treatments for Chronic Kidney Disease in the 21st Century.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Semin Nephrol       Date:  2016-11       Impact factor: 5.299

4.  Copy-number variation associated with congenital anomalies of the kidney and urinary tract.

Authors:  Georgina Caruana; Milagros N Wong; Amanda Walker; Yves Heloury; Nathalie Webb; Lilian Johnstone; Paul A James; Trent Burgess; John F Bertram
Journal:  Pediatr Nephrol       Date:  2014-10-01       Impact factor: 3.714

Review 5.  Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease.

Authors:  Matthew B Lanktree; Ioan-Andrei Iliuta; Amirreza Haghighi; Xuewen Song; York Pei
Journal:  Nephrol Dial Transplant       Date:  2019-09-01       Impact factor: 5.992

6.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions.

Authors:  Kelly D Farwell; Layla Shahmirzadi; Dima El-Khechen; Zöe Powis; Elizabeth C Chao; Brigette Tippin Davis; Ruth M Baxter; Wenqi Zeng; Cameron Mroske; Melissa C Parra; Stephanie K Gandomi; Ira Lu; Xiang Li; Hong Lu; Hsiao-Mei Lu; David Salvador; David Ruble; Monica Lao; Soren Fischbach; Jennifer Wen; Shela Lee; Aaron Elliott; Charles L M Dunlop; Sha Tang
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

7.  Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia.

Authors:  Nikhita Ajit Bolar; Christelle Golzio; Martina Živná; Gaëlle Hayot; Christine Van Hemelrijk; Dorien Schepers; Geert Vandeweyer; Alexander Hoischen; Jeroen R Huyghe; Ann Raes; Erve Matthys; Emiel Sys; Myriam Azou; Marie-Claire Gubler; Marleen Praet; Guy Van Camp; Kelsey McFadden; Igor Pediaditakis; Anna Přistoupilová; Kateřina Hodaňová; Petr Vyleťal; Hana Hartmannová; Viktor Stránecký; Helena Hůlková; Veronika Barešová; Ivana Jedličková; Jana Sovová; Aleš Hnízda; Kendrah Kidd; Anthony J Bleyer; Richard S Spong; Johan Vande Walle; Geert Mortier; Han Brunner; Lut Van Laer; Stanislav Kmoch; Nicholas Katsanis; Bart L Loeys
Journal:  Am J Hum Genet       Date:  2016-07-07       Impact factor: 11.025

8.  Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases.

Authors:  C Fallerini; L Dosa; R Tita; D Del Prete; S Feriozzi; G Gai; M Clementi; A La Manna; N Miglietti; R Mancini; G Mandrile; G M Ghiggeri; G Piaggio; F Brancati; L Diano; E Frate; A R Pinciaroli; M Giani; P Castorina; E Bresin; D Giachino; M De Marchi; F Mari; M Bruttini; A Renieri; F Ariani
Journal:  Clin Genet       Date:  2013-10-17       Impact factor: 4.438

Review 9.  The role of hepatocyte nuclear factor 1β in disease and development.

Authors:  R El-Khairi; L Vallier
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

10.  The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.

Authors:  Elfrida R Benjamin; Maria Cecilia Della Valle; Xiaoyang Wu; Evan Katz; Farhana Pruthi; Sarah Bond; Benjamin Bronfin; Hadis Williams; Julie Yu; Daniel G Bichet; Dominique P Germain; Roberto Giugliani; Derralynn Hughes; Raphael Schiffmann; William R Wilcox; Robert J Desnick; John Kirk; Jay Barth; Carrolee Barlow; Kenneth J Valenzano; Jeff Castelli; David J Lockhart
Journal:  Genet Med       Date:  2016-09-22       Impact factor: 8.822

View more
  8 in total

Review 1.  The genetic basis of congenital anomalies of the kidney and urinary tract.

Authors:  Maayan Kagan; Oren Pleniceanu; Asaf Vivante
Journal:  Pediatr Nephrol       Date:  2022-02-04       Impact factor: 3.651

Review 2.  TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Alex Siu-Wing Chan; Cai-Bin Zhang; Cristina Alexandra García Córdoba; Ying-Ying Zhang; Ka-Fai To; Kam-Tong Leung; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Front Med (Lausanne)       Date:  2021-02-25

3.  MODY5 Hepatocyte Nuclear Factor 1ß (HNF1ß)-Associated Nephropathy: experience from a regional monogenic diabetes referral centre in Singapore.

Authors:  Clara Si Hua Tan; Su Fen Ang; Ester Yeoh; Bing Xing Goh; Wann Jia Loh; Cheuk Fan Shum; Molly May Ping Eng; Allen Yan Lun Liu; Lovynn Wan Ting Chan; Li Xian Goh; Tavintharan Subramaniam; Chee Fang Sum; Su Chi Lim
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 4.  How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside.

Authors:  Doloretta Piras; Nicola Lepori; Gianfranca Cabiddu; Antonello Pani
Journal:  J Pers Med       Date:  2022-01-31

5.  Developmental disorders caused by haploinsufficiency of transcriptional regulators: a perspective based on cell fate determination.

Authors:  Roman Zug
Journal:  Biol Open       Date:  2022-01-28       Impact factor: 2.422

6.  An accessible insight into genetic findings for transplantation recipients with suspected genetic kidney disease.

Authors:  Zhigang Wang; Hongen Xu; Tianchao Xiang; Danhua Liu; Fei Xu; Lixiang Zhao; Yonghua Feng; Linan Xu; Jialu Liu; Ye Fang; Huanfei Liu; Ruijun Li; Xinxin Hu; Jingyuan Guan; Longshan Liu; Guiwen Feng; Qian Shen; Hong Xu; Dmitrij Frishman; Wenxue Tang; Jiancheng Guo; Jia Rao; Wenjun Shang
Journal:  NPJ Genom Med       Date:  2021-07-02       Impact factor: 8.617

Review 7.  Look Alike, Sound Alike: Phenocopies in Steroid-Resistant Nephrotic Syndrome.

Authors:  Francesca Becherucci; Samuela Landini; Luigi Cirillo; Benedetta Mazzinghi; Paola Romagnani
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

Review 8.  Evolutionary genetics and acclimatization in nephrology.

Authors:  Adebowale A Adeyemo; Daniel Shriner; Amy R Bentley; Rasheed A Gbadegesin; Charles N Rotimi
Journal:  Nat Rev Nephrol       Date:  2021-09-28       Impact factor: 28.314

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.